High incidence of histological hepatitis and portal fibrosis at 1 year after pediatric liver transplantation using a tacrolimus-based immunosuppressive regimen

被引:0
|
作者
Scheenstra, R. [1 ,4 ]
Gouw, A. S. H. [2 ,4 ]
Peeters, P. M. J. [3 ,4 ]
Verkade, H. J. [1 ,4 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Gastroenterol, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Beatrix Children Hosp, Dept Pathol, NL-9713 AV Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatobiliary Surg, NL-9713 AV Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Liver Transplantat Team, NL-9713 AV Groningen, Netherlands
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A66 / A66
页数:1
相关论文
共 23 条
  • [1] HIGH INCIDENCE OF HISTOLOGICAL HEPATITIS AND PORTAL FIBROSIS AT 1 YEAR AFTER PEDIATRIC LIVER TRANSPLANTATION USING A TACROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMEN
    Scheenstra, Rene
    Gouw, Annette S.
    Peeters, Paul M.
    Verkade, Henkjan J.
    [J]. HEPATOLOGY, 2008, 48 (04) : 1033A - 1034A
  • [2] Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation
    Andres, A
    Toso, C
    Morel, P
    Demuylder-Mischler, S
    Bosco, D
    Baertschiger, R
    Pernin, N
    Bucher, P
    Majno, PE
    Bühler, LH
    Berney, T
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1326 - 1327
  • [3] IMPACT OF INDUCTION WITH BASILIXIMAB IN COMBINATION WITH TACROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMEN IN LIVING DONOR LIVER TRANSPLANTATION.
    Aoyagi, Takeshi
    Taniguchi, Masahiko
    Furukawa, Hiroyuki
    Shimamura, Tsuyoshi
    Suzuki, Tomomi
    Yamashita, Kenichiro
    Todo, Satoru
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S105 - S105
  • [4] New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen
    Zolota, A.
    Miserlis, G.
    Solonaki, F.
    Tranda, A.
    Antoniadis, N.
    Imvrios, G.
    Fouzas, I.
    [J]. TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3386 - 3391
  • [5] Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen
    Andres, A
    Toso, C
    Morel, P
    Demuylder-Mischler, S
    Bosco, D
    Baertschiger, R
    Pernin, N
    Bucher, P
    Majno, PE
    Bühler, LH
    Berney, T
    [J]. TRANSPLANT INTERNATIONAL, 2005, 18 (11) : 1226 - 1230
  • [6] Insulin independence in islet after kidney (IAK) transplant recipients using a sirolimus/tacrolimus-based steroid-free immunosuppressive regimen
    Berney, T
    Andres, A
    Bosco, D
    Baertschiger, R
    Bucher, P
    Toso, C
    Bühler, LH
    Morel, P
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 378 - 378
  • [7] Differences in the Incidence and Clinical Evolution of Early Neurotoxicity After Liver Transplantation Based on Tacrolimus Formulation Used in the Immunosuppressive Induction Protocol
    Souto-Rodriguez, R.
    Molina-Perez, E.
    Castroagudin, J. F.
    Fernandez Perez, A.
    Otero-Anton, E.
    Tome Martinez de Rituerto, S.
    Martinez-Castro, J.
    Varo-Perez, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 3117 - 3120
  • [8] Everolimus combined with low-dose tacrolimus controls histological graft injury and liver fibrosis as sufficiently as high-dose tacrolimus combined with mycophenolate after liver transplantation
    Dranicki, Fabian
    Saunders, Emily
    Kirchner, Theresa
    Engel, Bastian
    Hartleben, Bjoern
    Wedemeyer, Heiner
    Jaeckel, Elmar
    Taubert, Richard
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S784 - S785
  • [9] EVEROLIMUS COMBINED WITH LOW-DOSE TACROLIMUS CONTROLS HISTOLOGICAL GRAFT INJURY AND LIVER FIBROSIS AS SUFFICIENTLY AS HIGH-DOSE TACROLIMUS COMBINED WITH MYCOPHENOLATE AFTER LIVER TRANSPLANTATION
    Dranicki, F.
    Saunders, E. A.
    Kirchner, T.
    Guetzlaff, L. Y.
    Vollmann, K. H.
    Engel, B.
    Hartleben, B.
    Wedemeyer, H.
    Jaeckel, E.
    Taubert, R.
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 15 - 15
  • [10] Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation:: Ten-year follow-up
    Jonas, S
    Guckelberger, O
    Müller, AR
    Langrehr, JM
    Settmacher, U
    Tullius, SG
    Steinmüller, T
    Neuhaus, P
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1504 - 1506